KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Net Income (2016 - 2025)

Historic Net Income for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $8.9 million.

  • Staar Surgical's Net Income fell 1098.2% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.2 million, marking a year-over-year decrease of 30564.23%. This contributed to the annual value of -$64.0 million for FY2024, which is 19450.8% down from last year.
  • Latest data reveals that Staar Surgical reported Net Income of $8.9 million as of Q3 2025, which was down 1098.2% from -$16.8 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Net Income ranged from a high of $54.1 million in Q4 2023 and a low of -$78.0 million during Q4 2024
  • For the 5-year period, Staar Surgical's Net Income averaged around $3.0 million, with its median value being $8.0 million (2021).
  • Per our database at Business Quant, Staar Surgical's Net Income skyrocketed by 382537.31% in 2021 and then crashed by 152356.99% in 2025.
  • Over the past 5 years, Staar Surgical's Net Income (Quarter) stood at $22.0 million in 2021, then surged by 35.91% to $29.9 million in 2022, then soared by 81.24% to $54.1 million in 2023, then plummeted by 244.12% to -$78.0 million in 2024, then skyrocketed by 111.38% to $8.9 million in 2025.
  • Its Net Income stands at $8.9 million for Q3 2025, versus -$16.8 million for Q2 2025 and -$54.2 million for Q1 2025.